Key facts
- Douglas Evan Godshall has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $200,525.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Douglas Evan Godshall
- Location
- Sidney, Australia
- Summary
- The estimated net worth of Douglas Evan Godshall is at least $200,525 dollars as of 31 May 2024. Douglas Evan Godshall is the Director of EyePoint Pharmaceuticals, Inc. and owns shares of EyePoint, Inc. (EYPT) stock worth about $200.5K.
- Signature
- s/ Wade Estey, as attorney-in-fact for Douglas Godshall
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Douglas Evan Godshall and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: EyePoint Pharmaceuticals, Inc. ($200,525).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Douglas Evan Godshall
EYPT
Forms 3/4/5
EyePoint Pharmaceuticals, Inc.
- Relationship
- Director
- Holdings value
- $200,525
- Past year net change
- Change %
- Report period
- 22 Jun 2021
SWAV
Forms 3/4/5
Shockwave Medical, Inc.
- Relationship
- President & CEO, Director
- Holdings value
- $0
- Past year net change
- Change %
- Report period
- 31 May 2024
Insider Transactions Reported by Douglas Evan Godshall:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.